Simultaneous qualitative detection and differentiation of SARS-CoV-2 nucleocapsid antigen and/or influenza A and B nucleoprotein antigens directly from anterior nasal swab samples taken from individuals who are suspected of a viral respiratory infection consistent with COVID-19 by a healthcare provider, within the first six days of symptom onset. Emergency use of this test is limited to authorized laboratories.
Simplify the testing process - Easy operation and 1-button functionality may help reduce manual test processing errors
- Simple sample processing with color-coded tubes
Achieve fast, reliable results- Displays easy-to-read digital results for COVID-19 in 15 minutes: “CoV2: +” for positive, “CoV2: -” for negative
Provide workflow efficiency - Adapts easily to your workflow by offering 2 operational modes
- Walk away: Test device is insert
